Aprea Therapeutics, Inc. (APRE)
NASDAQ: APRE · Real-Time Price · USD
3.010
-0.010 (-0.33%)
Nov 20, 2024, 4:00 PM EST - Market closed
Aprea Therapeutics Employees
Aprea Therapeutics had 7 employees as of December 31, 2023. The number of employees decreased by 2 or -22.22% compared to the previous year.
Employees
7
Change (1Y)
-2
Growth (1Y)
-22.22%
Revenue / Employee
$187,263
Profits / Employee
-$1,929,595
Market Cap
16.36M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 7 | -2 | -22.22% |
| Dec 31, 2022 | 9 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Marinus Pharmaceuticals | 166 |
| Retractable Technologies | 151 |
| Flora Growth | 108 |
| Cumberland Pharmaceuticals | 91 |
| Cara Therapeutics | 55 |
| Nephros | 31 |
| IN8bio | 31 |
| Innovative Eyewear | 11 |
APRE News
- 4 weeks ago - Aprea Therapeutics Presents Preliminary Findings on Oral WEE1 Inhibitor APR-1051 at EORTC-NCI-AACR International Conference on Molecular Targets and Therapeutics - GlobeNewsWire
- 5 weeks ago - Aprea Therapeutics to Present at Maxim 2024 Healthcare Virtual Summit - GlobeNewsWire
- 5 weeks ago - Aprea Therapeutics Announces Presentations at EORTC-NCI-AACR International Conference on Molecular Targets and Therapeutics - GlobeNewsWire
- 6 weeks ago - Aprea Therapeutics Engages Philippe Pultar, MD to Serve as Senior Medical Advisor and Lead WEE1 Clinical Development - GlobeNewsWire
- 2 months ago - UPDATE - Aprea Therapeutics to Present at the H.C. Wainwright Annual Global Investment Conference - GlobeNewsWire
- 2 months ago - Aprea Therapeutics to Present at the H.C. Wainwright Annual Global Investment Conference - GlobeNewsWire
- 3 months ago - Aprea Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 5 months ago - Aprea Therapeutics to Host Virtual KOL Event on APR-1051, a Highly Selective and Potentially Best-in-Class Oral WEE1 Inhibitor, on Monday, June 24, 2024 - GlobeNewsWire